Paper40290331
PVAylation: precision end-functionalized poly(vinyl alcohol) for site-selective bioconjugation.
Soutar DE and 5 others. Chem Sci, 2025. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. PVAylation: precision end-functionalized poly(vinyl alcohol) for site-selective bioconjugation. Papers, record 40290331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40290331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PVAylation: precision end-functionalized poly(vinyl alcohol) for site-selective bioconjugation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21,706,630 | Efficient usage of thiocarbonates for both the production and the biofunctionalization of polymers. | Macromol Rapid Commun | 2009 | https://conductscience.org/library/papers/21706630 | PubMed |
| 2 | 33,555,493 | Grand Challenges in Pharmaceutical Research Series: Ridding the Cold Chain for Biologics. | Pharm Res | 2021 | https://conductscience.org/library/papers/33555493 | PubMed |
| 3 | 14,101,981 | AVIDIN. 3. THE NATURE OF THE BIOTIN-BINDING SITE. | Biochem J | 1963 | https://conductscience.org/library/papers/14101981 | PubMed |
| 4 | 12,469,133 | A general method for the covalent labeling of fusion proteins with small molecules in vivo. | Nat Biotechnol | 2003 | https://conductscience.org/library/papers/12469133 | PubMed |
| 5 | 31,478,286 | An Oxygen Paradox: Catalytic Use of Oxygen in Radical Photopolymerization. | Angew Chem Int Ed Engl | 2019 | https://conductscience.org/library/papers/31478286 | PubMed |
| 6 | 31,087,781 | Mimicking the Ice Recrystallization Activity of Biological Antifreezes. When is a New Polymer "Active"? | Macromol Biosci | 2019 | https://conductscience.org/library/papers/31087781 | PubMed |
| 7 | 29,863,329 | Polysarcosine as an Alternative to PEG for Therapeutic Protein Conjugation. | Bioconjug Chem | 2018 | https://conductscience.org/library/papers/29863329 | PubMed |
| 8 | 18,535,687 | Peptide/protein-polymer conjugates: synthetic strategies and design concepts. | Chem Commun (Camb) | 2008 | https://conductscience.org/library/papers/18535687 | PubMed |
| 9 | 40,881,838 | Precision Synthesis of End-Functionalized Star Poly(vinyl alcohol)s by RAFT Polymerization and Post-polymerization Modification. | Precis Chem | 2023 | https://conductscience.org/library/papers/40881838 | PubMed |
| 10 | 29,932,648 | Ice Recrystallization Inhibiting Polymers Enable Glycerol-Free Cryopreservation of Microorganisms. | Biomacromolecules | 2018 | https://conductscience.org/library/papers/29932648 | PubMed |
| 11 | 40,519,942 | RAFT with Light: A User Guide to Using Thiocarbonylthio Compounds in Photopolymerizations. | ACS Polym Au | 2025 | https://conductscience.org/library/papers/40519942 | PubMed |
| 12 | 7,697,996 | Nonequilibrium antifreeze peptides and the recrystallization of ice. | Cryobiology | 1995 | https://conductscience.org/library/papers/7697996 | PubMed |
| 13 | 33,311,718 | Ice recrystallisation inhibiting polymers prevent irreversible protein aggregation during solvent-free cryopreservation as additives and as covalent polymer-protein conjugates. | Eur Polym J | 2020 | https://conductscience.org/library/papers/33311718 | PubMed |
| 14 | 30,931,129 | Ice-recrystallization inhibiting polymers protect proteins against freeze-stress and enable glycerol-free cryostorage. | Mater Horiz | 2019 | https://conductscience.org/library/papers/30931129 | PubMed |
| 15 | 22,405,905 | Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor. | J Control Release | 2012 | https://conductscience.org/library/papers/22405905 | PubMed |
| 16 | 33,637,764 | The atomistic details of the ice recrystallisation inhibition activity of PVA. | Nat Commun | 2021 | https://conductscience.org/library/papers/33637764 | PubMed |
| 17 | 17,963,151 | Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. | Pharm Dev Technol | 2007 | https://conductscience.org/library/papers/17963151 | PubMed |
| 18 | 30,443,654 | A guide to maximizing the therapeutic potential of protein-polymer conjugates by rational design. | Chem Soc Rev | 2018 | https://conductscience.org/library/papers/30443654 | PubMed |
| 19 | 34,469,112 | Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies. | ACS Nano | 2021 | https://conductscience.org/library/papers/34469112 | PubMed |
| 20 | 33,722,756 | Polyvinyl alcohol based-drug delivery systems for cancer treatment. | Int J Pharm | 2021 | https://conductscience.org/library/papers/33722756 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40290331
GET https://conductscience.org/api/papers/v1/40290331/references?page=2